bisbenzimidazole has been researched along with Cancer of Pancreas in 3 studies
Bisbenzimidazole: A benzimidazole antifilarial agent; it is fluorescent when it binds to certain nucleotides in DNA, thus providing a tool for the study of DNA replication; it also interferes with mitosis.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Su, SB | 1 |
| Motoo, Y | 1 |
| Iovanna, JL | 1 |
| Berthézène, P | 1 |
| Xie, MJ | 1 |
| Mouri, H | 1 |
| Ohtsubo, K | 1 |
| Matsubara, F | 1 |
| Sawabu, N | 1 |
| Patel, SR | 1 |
| Kvols, LK | 1 |
| Rubin, J | 1 |
| O'Connell, MJ | 1 |
| Edmonson, JH | 1 |
| Ames, MM | 1 |
| Kovach, JS | 1 |
| Kraut, EH | 1 |
| Fleming, T | 1 |
| Segal, M | 1 |
| Neidhart, JA | 1 |
| Behrens, BC | 1 |
| MacDonald, J | 1 |
2 trials available for bisbenzimidazole and Cancer of Pancreas
| Article | Year |
|---|---|
Phase I-II study of pibenzimol hydrochloride (NSC 322921) in advanced pancreatic carcinoma.
Topics: Adult; Bisbenzimidazole; Carcinoma, Intraductal, Noninfiltrating; Drug Administration Schedule; Drug | 1991 |
Phase II study of pibenzimol in pancreatic cancer. A Southwest Oncology Group study.
Topics: Adenocarcinoma; Adult; Aged; Bisbenzimidazole; Drug Evaluation; Humans; Middle Aged; Pancreatic Neop | 1991 |
1 other study available for bisbenzimidazole and Cancer of Pancreas
| Article | Year |
|---|---|
Overexpression of p8 is inversely correlated with apoptosis in pancreatic cancer.
Topics: Aged; Aged, 80 and over; Apoptosis; Basic Helix-Loop-Helix Transcription Factors; Bisbenzimidazole; | 2001 |